等待开盘 07-01 09:30:00 美东时间
-0.220
-0.47%
今日重点评级关注:Chardan Capital:维持Ocular Therapeutix"买入"评级,目标价从21美元升至23美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从30美元升至40美元
06-26 17:42
Benchmark analyst Brett Rabatin initiates coverage on SmartFinancial (NYSE:SMBK) with a Buy rating and announces Price Target of $54.
06-25 18:04
SmartFinancial, Inc. $100,000,000 Common StockPreferred StockSenior Debt SecuritiesSubordinated Debt SecuritiesDepositary SharesPurchase ContractsUnitsWarrantsRights SmartFinancial, Inc. may
05-02 04:03
今日重点评级关注:HC Wainwright & Co.:维持Century Therapeutics"买入"评级,目标价从2美元升至5美元;Oppenheimer:维持Climb Bio"跑赢大市"评级,目标价从10美元升至18美元
04-22 12:41
Wall Street analysts update ratings on top names. B of A Sec raised CMS Energy Corp's price target to $88, Goldman Sachs raised Ramaco Resources Inc's target to $15, Truist Sec cut Packaging Corp's target to $260, Baird cut Mohawk Industries Inc's target to $118, Needham raised Crocs Inc's target to $132, HC Wainwright raised Century Therapeutics Inc's target to $5, and Morgan Stanley raised Arrowhead Pharmaceuticals Inc&#
04-21 19:56
Keefe, Bruyette & Woods analyst Catherine Mealor maintains SmartFinancial (NYSE:SMBK) with a Market Perform and raises the price target from $42 to $46.
04-21 19:01
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据SmartFinancial业绩会实录,以下是业绩回顾摘要: ## 1. 财务业绩 **收入表现:** - 运营收入达到5,380万美元,较上季度的5,330万美元增长,尽管本季度少了2个工作日 - 净利息收入为4,590万美元,较上季度增长78.2万美元 - 运营非利息收入为790万美元,较上季度略有下降 **盈利能力:** - 运营收益为1,370万美元,每股摊薄收益0.81美元 - 净利息利差(NIM)为3.48%,较上季度改善10个基点 - 运营效率比率维持在60%+水平 **资产质量:** - 不良资产占总资产比例仅为0.25%,维持高
04-21 12:07
SmartFinancial (NYSE:SMBK) released first-quarter financial results and hosted ...
04-20 22:42
Companies Reporting Before The Bell • SmartFinancial (NYSE:SMBK) is projected t...
04-20 19:11
SmartFinancial (NYSE:SMBK) reported quarterly earnings of $0.81 per share which beat the analyst consensus estimate of $0.78 by 3.85 percent. This is a 20.9 percent increase over earnings of $0.67 per share from the same
04-20 19:02